113 related articles for article (PubMed ID: 37252728)
1. Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort.
Khan N; Trivedi C; Shah Y; Patel M; Sundararajan R; Xie D; Yang YX
J Clin Gastroenterol; 2024 Mar; 58(3):277-280. PubMed ID: 37252728
[TBL] [Abstract][Full Text] [Related]
2. The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients.
Khan N; Patel D; Trivedi C; Pernes T; Kavani H; Xie D; Yang YX
Aliment Pharmacol Ther; 2022 Jan; 55(1):64-72. PubMed ID: 34664313
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study.
Khan N; Pernes T; Weiss A; Trivedi C; Patel M; Xie D; Yang YX
Adv Ther; 2021 May; 38(5):2586-2598. PubMed ID: 33844132
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of pneumonia among patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
[TBL] [Abstract][Full Text] [Related]
5. Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea.
Na JE; Jung SH; Choi A; Kim S; Kim TO
Mycoses; 2024 Jan; 67(1):e13689. PubMed ID: 38214414
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly patients with colorectal cancer: A population-based propensity score-matched cohort study.
Chiou WY; Hung SK; Lin HY; Chen LC; Hsu FC; Tsai SJ; Yu BH; Lee MS; Li CY
Medicine (Baltimore); 2019 Dec; 98(50):e18380. PubMed ID: 31852152
[TBL] [Abstract][Full Text] [Related]
7. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
[TBL] [Abstract][Full Text] [Related]
8. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
Khan N; Trivedi C; Aberra F; Pernes T; Yang YX
J Crohns Colitis; 2022 Sep; 16(9):1505-1507. PubMed ID: 35350070
[TBL] [Abstract][Full Text] [Related]
9. Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Diseases Receiving Treatment With Thiopurines.
Khan N; Lee H; Trivedi C; Kavani H; Medvedeva E; Xie D; Lewis JD; Yang YX
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2262-2268. PubMed ID: 30853615
[TBL] [Abstract][Full Text] [Related]
10. The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
Gregory MH; Ciorba MA; Wiitala WL; Stidham RW; Higgins P; Morley SC; Hou JK; Feagins LA; Govani SM; Cohen-Mekelburg SA; Waljee AK
Inflamm Bowel Dis; 2020 May; 26(6):919-925. PubMed ID: 31504531
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort study.
Kristensen SL; Ahlehoff O; Lindhardsen J; Erichsen R; Lamberts M; Khalid U; Nielsen OH; Torp-Pedersen C; Gislason GH; Hansen PR
Circ Heart Fail; 2014 Sep; 7(5):717-22. PubMed ID: 25052190
[TBL] [Abstract][Full Text] [Related]
12. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.
Kirchgesner J; Nyboe Andersen N; Carrat F; Jess T; Beaugerie L;
Gut; 2020 May; 69(5):852-858. PubMed ID: 31446428
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
14. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract][Full Text] [Related]
15. Effect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort Study.
Chiou WY; Hung SK; Lai CL; Lin HY; Su YC; Chen YC; Shen BJ; Chen LC; Tsai SJ; Lee MS; Li CY
Medicine (Baltimore); 2015 Jul; 94(26):e1022. PubMed ID: 26131806
[TBL] [Abstract][Full Text] [Related]
16. Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia.
Elemraid MA; Rushton SP; Shirley MD; Thomas MF; Spencer DA; Eastham KM; Hampton F; Gorton R; Pollard K; Gennery AR; Clark JE;
Epidemiol Infect; 2013 Aug; 141(8):1697-704. PubMed ID: 23084696
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.
Khan N; Mahmud N
Gastroenterology; 2021 Sep; 161(3):827-836. PubMed ID: 34048782
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
[TBL] [Abstract][Full Text] [Related]
19. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I
Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]